1. Xiao RP, Cheng H, Zhou Z, Chen Y, Wu C, Gu XC. Is China ready to go mainstream in molecular medicine? Nature. 2004,432: 42-45.
2. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H.Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends in Pharmacological Sciences (TiPS).2004, 25: 358-365.
3. Wang SQ, Wei C, Zhao G, Brochet DX, Shen J, Song LS, Wang W, Yang D, Cheng H. Imaging microdomain Ca2+ in muscle cells. Circ. Res. 2004, 94(8): 1011-22.
4. Wang W, Zhu W, Wang S, Yang D, Crow MT, Xiao RP, Cheng H. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ. Res. 2004, 95:798-806.
5. Pepe S, van den Brink OW, Lakatta EG, Xiao RP.Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovascular Research. 2004, 63: 414-22.
6. Leblais V, Jo SH, Chakir K, Maltsev V, Zheng M, Crow MT, Wang W, Lakatta EG, Xiao RP. Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. Circ. Res. 2004, 95:1183-90.